1887

Abstract

Vaccine-associated paralytic poliomyelitis is a serious concern while using the live attenuated oral polio vaccine for the eradication of poliomyelitis. The bonnet monkey model of poliovirus central nervous system (CNS) infection following experimental inoculation into the ulnar nerve allows the comparative study of wild-type and attenuated poliovirus invasiveness. Dosages ⩾10 TCID of Mahoney strain of poliovirus type 1 [PV1(M)] result in paralysis. In contrast, even with 10 TCID of Sabin attenuated strain of poliovirus type 1 (LSc/2ab), no paralysis occurs, but virus spreads into the CNS where viral RNA is found in spinal cord neurons. While wild-type PV1(M) viral RNA replicates in neurons (and possibly in glial cells) and in cells around vessel walls, which may be mononuclear or endothelial cells, attenuated viral RNA is detected only in neurons. Systemic viraemia and gastrointestinal virus shedding occurs only in PV1(M)-infected animals. While a systemic serologic response is detected in both groups of animals, cerebrospinal fluid antibodies are detected only in animals infected with PV1(M). Both the PV1(M) and LSc/2ab strains spread to the cervical spinal cord and then to the lumbar spinal cord following ulnar nerve inoculation. Neuronophagia and neuronal loss are only seen in PV1(M)-infected monkeys in whom clinical paralysis is observed. Infection with LSc/2ab does not result in neuronophagia, neuronal loss or clinical paralysis. Spread of attenuated poliovirus in spinal cord neurons without causing paralysis following inoculation into the ulnar nerve is an important finding.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-82-6-1329
2001-06-01
2024-05-05
Loading full text...

Full text loading...

/deliver/fulltext/jgv/82/6/0821329a.html?itemId=/content/journal/jgv/10.1099/0022-1317-82-6-1329&mimeType=html&fmt=ahah

References

  1. Agol V. I., Drozdov S. G., Ivanikova T. A., Kelesnikova M. S., Korolev M. B., Tolskaya E. A. 1989; Restricted growth of attenuated poliovirus strains in cultured cells of a human neuroblastoma. Journal of Virology 63:4034–4038
    [Google Scholar]
  2. Bernstein H. D., Sonenberg H., Baltimore D. 1985; Poliovirus mutant that does not selectively inhibit host cell protein synthesis. Molecular and Cellular Biology 5:2913–2923
    [Google Scholar]
  3. Couderc T., Christodoulou C., Kopecka H., Marsden B., Taffs L. F., Crainic R., Horaud F. 1989; Molecular pathogenesis of neural lesions induced by poliovirus type 1. Journal of General Virology 70:2907–2916
    [Google Scholar]
  4. Freidrich F., Fillips A. M. B., Ferreira F. C., Oliveira M. J. C., Schatzmayr H. C., Da-Silva E. E. 1996; Poliovirus type 1 isolated from a vaccine-associated case of paralytic poliomyelitis in Brazil. Brazilian Journal of Medical and Biological Research 29:15–18
    [Google Scholar]
  5. Georgescu M. M., Delpeyroux F., Tardy Panit M., Balanant J., Combiescu M., Combiescu A. A., Guillot S., Crainic R. 1994; High diversity of poliovirus strains isolated from the central nervous system from patients with vaccine-associated paralytic poliomyelitis. Journal of Virology 68:8089–8101
    [Google Scholar]
  6. Gromeier M., Wimmer E. 1998; Mechanism of injury-provoked poliomyelitis. Journal of Virology 72:5056–5060
    [Google Scholar]
  7. John T. J., Nambiar A., Samuel B. U., Rajasingh J. 1992; Ulnar nerve inoculation of poliovirus in bonnet monkey, a new primate model to investigate neurovirulence. Vaccine 10:529–532
    [Google Scholar]
  8. Kanda Y., Melnick J. L. 1959; In vitro differentiation of virulent and attenuated polioviruses by their growth characteristics on MS cells. Journal of Experimental Medicine 109:924
    [Google Scholar]
  9. Koike S., Taya C., Kurata T., Abe S., Ise I., Yonekawa H., Nomoto A. 1991; Transgenic mice susceptible to poliovirus. Proceedings of the National Academy of Sciences, USA 88:951–955
    [Google Scholar]
  10. Minor P. D. 1997; Immunization of pregnant women could protect babies from vaccine-associated poliomyelitis. Vaccine 15:1709
    [Google Scholar]
  11. Monica N. L., Racaniello V. R. 1989; Differences in replication of attenuated and neurovirulent polioviruses in human neuroblastoma cell line SHSY5Y. Journal of Virology 63:2357–2360
    [Google Scholar]
  12. Morrison L., Fields B. N. 1992; Parallel mechanisms in neuropathogenesis of enteric virus infections. Journal of Virology 65:2767–2772
    [Google Scholar]
  13. Ohka S., Yang W., Terada E., Iwasaki K., Nomoto A. 1998; Retrograde transport of intact poliovirus through the axon via the fast transport system. Virology 250:67–78
    [Google Scholar]
  14. Peters J. B., Bowman R. L. 1992; Intra-blood–brain barrier synthesis of IgG. Comparison of IgG synthesis formulae in a computer model and 1629 consecutive specimens. Neurology 42:510–515
    [Google Scholar]
  15. Peters T. Jr, Biamonte G. T., Doumas B. T. 1982; Protein (total protein) in serum, urine and cerebrospinal fluid, albumin in serum. In Selected Methods of Clinical Chemistry pp 161–245 Edited by Faulkner W. R., Meites S. Washington, DC: American Association of Clinical Chemistry;
    [Google Scholar]
  16. Ponnuraj E. M., John T. J., Levin M. J., Simoes E. A. F. 1998; Cell-to-cell spread of poliovirus in the spinal cord of bonnet monkeys ( Macaca radiata ). Journal of General Virology 79:2393–2403
    [Google Scholar]
  17. Racaniello V. R. 1988; Poliovirus neurovirulence. Advances in Virus Research 34:217–246
    [Google Scholar]
  18. Ren R., Racaniello V. R. 1992; Poliovirus spreads from muscle to the central nervous system by neural pathways. Journal of Infectious Diseases 166:747–752
    [Google Scholar]
  19. Ren R. B., Costantini F., Gorgacz E. J., Lee J. J., Racaniello V. R. 1990; Transgenic mice expressing a human poliovirus receptor: a new model for poliomyelitis. Cell 63:353–362
    [Google Scholar]
  20. Samuel B. U., Indrasingh I., Chandi G., John T. J. 1992; Ultrastructural specialization of intestinal epithelium over Peyer’s patches in the bonnet monkey, Macaca radiata . Indian Journal of Experimental Biology 30:1138–1141
    [Google Scholar]
  21. Samuel B. U., Ponnuraj E. M., Singh R., John T. J. 1993; Experimental poliomyelitis in bonnet monkey. Clinical features, virology and pathology. Developments in Biological Standardization 78:71–78
    [Google Scholar]
  22. Sicinski P., Rowiski J., Warchol J. B., Jarzabek V., Gut W., Szczgiel B., Bielecki K., Koch G. 1990; Poliovirus type I enters the human host through intestinal M cells. Gastroenterology 98:56–58
    [Google Scholar]
  23. Strebel P. M., Aubert-Combiescu A., Ion-Nedelcu N., Biberi-Moroeanu S., Combiescu M., Sutter R. W., Kew O. M., Pallansch M. A., Patriarca P. A., Cochi S. L. 1994; Paralytic poliomyelitis in Romania; 1984–1992; Evidence for a high risk of vaccine-associated disease and reintroduction of wild-virus infection. American Journal of Epidemiology 140:1111–1124
    [Google Scholar]
  24. Strebel P. M., Ion-Nedelcu N., Baughman A. L., Sutter R. W., Cochi S. L. 1995; Intramuscular injections within 30 days of immunization with oral poliovirus vaccine–a risk factor for vaccine-associated paralytic poliomyelitis. New England Journal of Medicine 332:500–506
    [Google Scholar]
  25. Sutter R. W., Patriarca P. A., Suleiman A. J., Brogan S., Malankar P. G., Cochi S. L., Al-Ghassani A. A., el Bualy M. S. 1992; Attributable risk of DPT (diptheria and tetanus toxoids and pertussis vaccine) injection in provoking paralytic poliomyelitis during a large outbreak in Oman. Journal of Infectious Diseases 165:444–449
    [Google Scholar]
  26. Svitkin Y. V., Maslova S. V., Agol V. I. 1985; The genome of attenuated and virulent poliovirus strains differ in their in vitro translation efficiencies. Virology 147:243–253
    [Google Scholar]
  27. Svitkin Y. V., Pestova T. V., Maslova S. V., Agol V. I. 1988; Point mutations modify the response of poliovirus RNA to a translation initiation factor: a comparison of neurovirulent and attenuated strains. Virology 166:394–404
    [Google Scholar]
  28. Tershak D. R., Makkar R. 1988; Attachment, uncoating and blockage of cell protein synthesis by Sabin derivatives of poliovirus in HeLa and Vero cells. Intervirology 29:292–300
    [Google Scholar]
  29. WHO 1982; Expert committee on biological standardization. Requirements for poliomyelitis vaccine (oral). WHO Technical Report Series no. 658107–174
    [Google Scholar]
  30. WHO 1992; Manual for the Virological Investigation of Poliomyelitis . pp 29–46 Edited by the Expanded Programme on Immunization and Division of Communicable Diseases Geneva, Switzerland: World Health Organization;
    [Google Scholar]
  31. Wyatt H. V. 1989; Poliomyelitis in developing countries: lower limb paralysis and injections. Transactions of the Royal Society of Tropical Medicine and Hygiene 83:545–549
    [Google Scholar]
  32. Yang W. X., Terasaki T., Shiroki K., Ohka S., Aoki J., Tanabe S., Nomura T., Terada E., Sugiyama Y., Nomoto A. 1997; Efficient delivery of circulating poliovirus to the central nervous system independently of poliovirus receptor. Virology 229:421–428
    [Google Scholar]
  33. Zhang S., Racaniello V. R. 1997; Expression of the poliovirus receptor in intestinal epithelial cells is not sufficient to permit poliovirus replication in the mouse gut. Journal of Virology 71:4915–4920
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-82-6-1329
Loading
/content/journal/jgv/10.1099/0022-1317-82-6-1329
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error